Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Pfizer Consumer Healthcare

02 7Pfizer Inc

03 1Wyeth Pharmaceuticals Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab ozogamicin

Brand Name : Besponsa

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab ozogamicin

Brand Name : Besponsa

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab ozogamicin

Brand Name : Besponsa

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab ozogamicin

Brand Name : Besponsa

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumabum Ozogamicinum

Brand Name : Besponsa

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 1mg

Packaging :

Approval Date : 10/07/2017

Application Number : 66022

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab ozogamicin

Brand Name : Besponsa

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

07

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab ozogamicin

Brand Name : Besponsa

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab Ozogamicin

Brand Name : Besponsa

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 1MG

Packaging :

Approval Date : 21-07-2017

Application Number : 1171200001

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumab Ozogamicin

Brand Name : Sponsored

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength :

Packaging :

Approval Date : 29-06-2017

Application Number : 28105771516

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Inotuzumabozogamicin

Brand Name : Besponsa

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength :

Packaging :

Approval Date : 29-06-2017

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

11

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

INOTUZUMAB OZOGAMICIN

Brand Name : BESPONSA

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 0.9MG/VIAL

Packaging :

Approval Date :

Application Number : 2473909

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank

12

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

INOTUZUMAB OZOGAMICIN

Brand Name : BESPONSA

Dosage Form : POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER

Dosage Strength : 0.9/MG/VIAL

Packaging :

Approval Date :

Application Number : 761040

Regulatory Info :

Registration Country : USA

blank